Generation of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene

被引:1
|
作者
Driver, Karrison [1 ,2 ]
Vo, Christina [1 ,2 ]
Scriba, Carolin K. [1 ,2 ,3 ]
Saker, Safaa [4 ]
Larmonier, Thierry [4 ]
Malfatti, Edoardo [5 ,6 ]
Romero, Norma B. [7 ,8 ]
Ravenscroft, Gianina [1 ,2 ]
Laing, Nigel G. [1 ,2 ]
Taylor, Rhonda L. [1 ,2 ]
Clayton, Joshua S. [1 ,2 ]
机构
[1] QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia
[2] Univ Western Australia, QEII Med Ctr, Ctr Med Res, Nedlands, WA, Australia
[3] QEII Med Ctr, Dept Diagnost Genom, Neurogenet Lab, PP Block, Nedlands, WA, Australia
[4] Genethon, DNA & Cell Bank, F-91000 Evry, France
[5] Henri Mondor Hosp, APHP, Ctr Reference Pathol Neuromusculaire Nord Est Ile, Creteil, France
[6] Univ Paris Est, INSERM, U955, IMRB, F-94010 Creteil, France
[7] Sorbonne Univ, Myol Inst, Ctr Res Myol, Neuromuscular Morphol Unit,GH Pitie Salpetriere, Paris, France
[8] GHU Pitie Salpetriere, Assistance Publ Hop Paris, Ctr Reference Pathol Neuromusculaire Paris Est, Paris, France
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.scr.2023.103258
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Central core disease (CCD) is a congenital disorder that results in hypotonia, delayed motor development, and areas of reduced oxidative activity in the muscle fibre. Two induced pluripotent stem cell (iPSC) lines were generated from the lymphoblastoid cells of a 33-year-old male with CCD, caused by a previously unreported dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene. Both lines demonstrated typical morphology, pluripotency, tri-lineage differentiation, and had a normal karyotype. As the first published iPSC model of CCD caused by an RYR1 variant these lines are a potential resource for further investigation of RYR1-related myopathies in a human context.
引用
收藏
页数:6
相关论文
共 6 条
  • [1] Generation of two isogenic induced pluripotent stem cell lines from a 10-year-old typical nemaline myopathy patient with a heterozygous dominant c.541G>A (p.Asp179Asn) pathogenic variant in the ACTA1 gene
    Clayton, Joshua S.
    Scriba, Carolin K.
    Romero, Norma B.
    Malfatti, Edoardo
    Saker, Safaa
    Larmonier, Thierry
    Nowak, Kristen J.
    Ravenscroft, Gianina
    Laing, Nigel G.
    Taylor, Rhonda L.
    STEM CELL RESEARCH, 2021, 55
  • [2] Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 gene
    Clayton, Joshua S.
    Scriba, Carolin K.
    Romero, Norma B.
    Malfatti, Edoardo
    Saker, Safaa
    Larmonier, Thierry
    Nowak, Kristen J.
    Ravenscroft, Gianina
    Laing, Nigel G.
    Taylor, Rhonda L.
    STEM CELL RESEARCH, 2021, 53
  • [3] Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p Ala172Glu) variant in the ACTA1 gene .
    Clayton, Joshua S.
    Suleski, Isabella
    Vo, Christina
    Smith, Robert
    Scriba, Carolin K.
    Saker, Safaa
    Larmonier, Thierry
    Malfatti, Edoardo
    Romero, Norma B.
    Houweling, Peter J.
    Nowak, Kristen J.
    Ravenscroft, Gianina
    Laing, Nigel G.
    Taylor, Rhonda L.
    STEM CELL RESEARCH, 2022, 63
  • [4] Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old nemaline myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene
    Suleski, Isabella S.
    Smith, Robert
    Vo, Christina
    Scriba, Carolin K.
    Saker, Safaa
    Larmonier, Thierry
    Malfatti, Edoardo
    Romero, Norma B.
    Houweling, Peter J.
    Nowak, Kristen J.
    Laing, Nigel G.
    Taylor, Rhonda L.
    Clayton, Joshua S.
    STEM CELL RESEARCH, 2022, 63
  • [5] p Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson?s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p. T610A) in the RHOT1 gene encoding Miro1
    Chemla, Axel
    Arena, Giuseppe
    Saraiva, Claudia
    Berenguer-Escuder, Clara
    Grossmann, Dajana
    Grunewald, Anne
    Klein, Christine
    Seibler, Philip
    Schwamborn, Jens C.
    Kruger, Rejko
    STEM CELL RESEARCH, 2023, 69
  • [6] Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p. R450C) in the RHOT1 gene encoding Miro1
    Chemla, Axel
    Arena, Giuseppe
    Onal, Gizem
    Walter, Jonas
    Berenguer-Escuder, Clara
    Grossmann, Dajana
    Grunewald, Anne
    Schwamborn, Jens C.
    Kruger, Rejko
    STEM CELL RESEARCH, 2023, 71